Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00238914 · ClinicalTrials.gov registry record · Phase 2
Opiate Dependence: Combined Naltrexone/Behavior Therapy - 1
A Phase 2 study of Heroin Dependence, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- Phase 2
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT00238914 is a Phase 2 study of Heroin Dependence that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 12 participants, below the 108-participant average among 8 other Heroin Dependence trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00238914, a Phase 2 study of Heroin Dependence, has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall goal of this research project is to test a newly developed behavioral therapy to enhance the efficacy of naltrexone maintenance and make it a viable alternative to methadone maintenance or detoxification methods for treatment of opiate dependence. HYPOTHESES: 1. Outpatient treatment with Behavioral Naltrexone Therapy will yield a lower rate of relapse to illicit opiates compared to naltrexone plus Compliance Enhancement (CE) Therapy. 2. Lifetime history of depression will predict dysphoria and non-compliance with naltrexone.
Conditions Studied
Interventions
- DRUG Naltrexone
- BEHAVIORAL Behavioral Naltrexone Therapy (BNT)
- BEHAVIORAL Compliance Enhancement (CE)
Study Locations (1)
New York
- New York State Psychiatric Institute - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 1999-08 |
| Est. Completion | 2002-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00238914
The ClinicalTrials.gov registry entry for NCT00238914 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 108-participant average among 8 other Heroin Dependence trials with a reported enrollment target (89% lower). The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Heroin Dependence appearing as the primary indexed condition, and to 3 interventions - of which Naltrexone is the first listed.
NCT00238914 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT00238914 about?
NCT00238914 is a clinical study titled "Opiate Dependence: Combined Naltrexone/Behavior Therapy - 1". The overall goal of this research project is to test a newly developed behavioral therapy to enhance the efficacy of naltrexone maintenance and make it a viable alternative to methadone maintenance or detoxification methods for treatment of opiate dependence. HYPOTHESES: 1. Outpatient treatment wit...
What is the current status of trial NCT00238914?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 12 participants. The study started on 1999-08. Estimated completion is 2002-07.
What conditions does trial NCT00238914 study?
This clinical trial studies the following conditions: Heroin Dependence.
What interventions are being tested in trial NCT00238914?
The interventions under investigation include: Naltrexone (DRUG), Behavioral Naltrexone Therapy (BNT) (BEHAVIORAL), Compliance Enhancement (CE) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00238914?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00238914 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heroin Dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Directly Administered HIV Therapy in Methadone Clinics
COMPLETED · Phase 2
-
Treatment of Opioid/Heroin Dependence: Comparison of Three Medication Dosing Regimens
COMPLETED · Phase 2
-
The Efficacy of Methadyl Acetate (LAAM) and Contingency Management Procedures for Treating Dual Opioid and Cocaine Abuse - 1
COMPLETED · Phase 2
-
A Laboratory Model for Heroin Abuse Medications - 8
COMPLETED · Phase 2
-
Study of Computer-Based Treatment for Drug Dependence
COMPLETED · Phase 2
-
Reinforcing Effects of Intranasal (IN) Buprenorphine Versus Buprenorphine/Naloxone
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.